Medicine for treating rheumatoid and preparation method thereof

Abstract

The invention relates to the field of traditional Chinese pharmacology, in particular to a medicine for treating rheumatoid and a preparation method thereof. The medicine is prepared from the following raw materials of wild fungi pine lucid ganoderma, fomitopsis pinicola, laricifomes officinalis, polyporus, ganoderma applanatum, chaga, trametes orientalis, piptoporus betulinus, ganoderma lucidum,and pyropolyporus fomentarius, and geo-authentic crude drugs of radix aconiti, radix aconiti agrestis, rhizoma gastrodiae, radix notoginseng, herba asari, radix stephaniae tetrandrae, radix saposhnikoviae, rhizoma et radix notopterygii, radix angelicae pubescentis, radix gentianae macrophyllae, semen strychni, lumbricus, fructus chaenomelis, scorpion, centipede, ramulus mori, radix cyathulae, rhizoma chuanxiong, rhizoma atractylodis, cortex cinnamomi, radix aconiti carmichaeli, radix clematidis, caulis sinomenii and minium, wherein the raw materials are decocted by cannabis oil, so as to obtain an external ointment. Proofed by clinical test, the medicine has the advantages that the ideal treatment function on the rheumatoid is realized; the poor reaction is little, the safety property is good, the convenience in use is realized, and the tolerance and obedience of a patient are high.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating rheumatism and a preparation method thereof. Background technique [0002] Rheumatism is a group of diseases mainly characterized by invasion of joints, bones, muscles, blood vessels and related soft or connective tissues, most of which are autoimmune diseases. It is generally believed that all diseases that cause bone, joint and muscle pain can be classified as rheumatism, mainly including rheumatoid arthritis, scleroderma, ankylosing spondylitis, osteoarthritis, rheumatic fever, systemic lupus erythematosus, systemic Sexual sclerosis, dermatomyositis and other diseases. Patients may have symptoms such as headache, fever, sweating, bad wind, weight, difficulty urinating, joint pain, swelling, inability to flex or extend, movement disorders, muscle stiffness, etc., which can cause damage to various tissues and organs and affect their normal fun...

AI Technical Summary

Problems solved by technology

[0004] However, as the most important and effective means of treating rheumatism, the above-mentioned various clinical drugs still have many shortcomings. The treatment effect is not satisfactory, and its adverse effects on the gastrointestinal tract, kidney, liver and blood system are more significant, so its application is largely limited; the adverse reactions of adrenal cortex hormones are serious, and long-term use can make patients dependent Sex, not only can not prevent the development of the disease and joint damage, but also cause water and salt metabolism and sugar, fat, protein metabolism disorders, and can induce severe infection, osteoporosis, femoral head necrosis, peptic ulcer, high blood pressure, mental disorders etc.; slow-acting antirheumatic drugs take effect slowly and often take 3-6 months, so they cannot be used to relieve acute clinical symptoms, and they will have certain effects on liver, kidney, bladder, lung, gastrointestinal tract, gonad and bone marrow biological agents have a narrow spectrum of diseases and are very expensive; although pure herbal medicines have certain curative effects, the mechanism of action is often unknown, and the therapeutic effect on patients with severe clinical symptoms is not ideal

[0005] To sum up, it can be seen that due to the current various therapeutic drugs for rheumatism have great limitations in the use process, therefore, there are still quite a lot of patients who cannot be treated satisfactorily.